• Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
HBOT News Network Logo
  • Home
  • Special Reports
  • News & Research
  • Conversations
  • Research Rundowns
  • International Indications
Veterans Special Report
  • Home
  • Special Reports
  • News & Research
  • Conversations
  • Research Rundowns
  • International Indications

Radiotherapy and hyperbaric oxygen in head and neck cancer. Final report of first controlled clinical trial.

by HBOT News | Jul 16, 1977 | Carcinoma

Abstract: We report the results of a prospective controlled trial of the effect of hyperbaric oxygen as an adjuvant in radiotherapy of head and neck cancer. Patients were allocated randomly to treatment in oxygen or air. The radiotherapy in both groups was identical...

Radiotherapy and hyperbaric oxygen in head and neck cancer. Interim report of second clinical trial.

by HBOT News | Jul 16, 1977 | Carcinoma

Abstract: A controlled clinical trial is in progress to assess the value of hyperbaric oxygen and radiotherapy in the management of head and neck cancer. An established dose-fractionation schedule in hyperbaric oxygen is being compared with a widely used conventional...

Measurement of tritiated thymidine labeling index by incubation in vitro of surgically removed cervical cancer.

by HBOT News | Jun 1, 1977 | Carcinoma

Abstract: Autoradiographic study was made on 24 cases of uterine cervical tumor, including 22 cases of squamous cell carcinoma, using a technique of in vitro labeling of surgical specimens with tritiated thymidine (3H-TdR) under hyperbaric oxygen. Labeling index of...

[Endoscopic and x-ray evaluation of the effectiveness of the gamma therapy of lung cancer under hyperbaric oxygenation].

by HBOT News | Mar 1, 1977 | Cancer

Abstract: Maksimov, Lebedev, Zvekotkina, Pitskhelauri, Dar’ialov, , , , (1977). [Endoscopic and x-ray evaluation of the effectiveness of the gamma therapy of lung cancer under hyperbaric oxygenation]. Meditsinskaia radiologiia, 1977...

Hyperbaric oxygen as a radiotherapeutic adjuvant in advanced cancer of the uterine cervix: preliminary results of a randomized trial.

by HBOT News | Feb 1, 1977 | Cancer

Abstract: From September 1968 to March 1974, a randomized clinical trial was carried out, using conventional fractionation, i.e., five treatments per week, in 233 patients with advanced cancers of the uterine cervix–Stages IIB, IIA, IIIB and IVA. The age limit...
« Older Entries
Next Entries »

Recent Posts

  • Treat the Concussion: How HBOT Is Changing the Playbook for Concussions — An Interview with Dr. Daphne Denham
  • Understanding Hyperbaric Chambers: Types, Risks, and Safety Tips for Patients
  • Overcoming the Placebo Challenge: New Trial Confirms HBOT Benefits for TBI and PTSD
  • Concussion Recovery: New Study Supports HBOT for Student Athletes
  • Can Oxygen Make You Younger? What Bryan Johnson’s $2M HBOT Experiment Really Tells Us

Archives

Categories

Hyperbaric Oxygen Therapy is used around the world to extend and improve quality of life by augmenting the treatment of all injuries, diseases and infections, as well as to improve overall wellness. HBOT involves breathing 100% oxygen in a pressurized chamber to increase oxygen levels in blood plasma. A century of clinical research has shown that increased oxygen in plasma accelerates our natural ability to heal through neurogenesis and angiogenesis.
  • Follow
  • Follow
  • Follow
  • Follow
  • Policies
  • Contact

Our Newsletter

Join our mailing list and get notified when we publish news or record new episodes.

Name(Required)

© 2015-2023 HBOT News – Your news source for the latest news and research about hyperbaric oxygen therapy.